or
forgot password

    • cancer clinical trials in asheville, NC

    • Assessment and Tracking of Long-term Alefacept Safety
    Skyland Dermatology and Psychiatry
    Asheville, North Carolina 28803
    Psoriasis
    First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
    Cancer Care of Western North Carolina
    Asheville, North Carolina 28801
    Lung Cancer
    Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
    Allergy Partners of Western North Carolina
    Asheville, North Carolina 28801
    Hereditary Angioedema
    Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
    Mission Hospital, Inc
    Asheville, North Carolina 28801
    Venous Thrombosis, Pulmonary Embolism
    Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)
    Allergy Partners of Western North Carolina
    Asheville, North Carolina 28801
    Hereditary Angioedema
    Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Colorectal Neoplasms
    Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
    Cancer Care of Western North Carolina
    Asheville, North Carolina 28801
    Cachexia
    Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Breast Neoplasms
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Mission Hospitals - Memorial Campus
    Asheville, North Carolina 28801
    Leukemia
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Hope A Women's Cancer Center
    Asheville, North Carolina 28801
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease
    Research Site
    Asheville, North Carolina
    Breast Cancer, Prostate Cancer, Bone Neoplasms
    Panitumumab DDI Irinotecan
    Research Site
    Asheville, North Carolina
    Metastatic Colorectal Cancer
    Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma
    Research Site
    Asheville, North Carolina
    Non-Hodgkin's Lymphoma
    Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Hematologic Neoplasms
    Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung
    Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Cancer Care of Western North Carolina
    Asheville, North Carolina 28801
    Non-Small Cell Lung Cancer
    Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer
    Cancer Care of Western North Carolina
    Asheville, North Carolina 28801
    Breast Cancer
    A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
    Research Site
    Asheville, North Carolina
    Adenocarcinoma of the Pancreas, Metastatic Pancreatic Cancer, Pancreatic Cancer
    Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
    Research Site
    Asheville, North Carolina
    Non-metastatic Prostate Cancer
    A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer
    Research Site
    Asheville, North Carolina
    Bladder Cancer, Transitional Cell Bladder Cancer, Urethra Cancer, Ureter Cancer, Renal Pelvis Cancer
    ChemoFx® PRO - A Post-Market Data Collection Study
    Hope: A Women's Cancer Center
    Asheville, North Carolina 28806
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer
    Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
    Mission Hospitals - Memorial Campus
    Asheville, North Carolina 28801
    Unspecified Childhood Solid Tumor, Protocol Specific
    APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
    Cancer Care of WNC, PA
    Asheville, North Carolina 28801
    Pancreatic Cancer, Metastatic Pancreatic Cancer
    Follow-Up Study for Exubera
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Diabetes Mellitus
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    Asheville Gastroenterology Associates, P.A.
    Asheville, North Carolina 28801
    Crohn's Disease
    Rollover Protocol for Prior SU011248 Protocols
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Solid Tumors
    Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Menopause, Osteoporosis
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Mission Hospitals Inc
    Asheville, North Carolina 28801
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening
    Asheville Gastroenterology Associates PA
    Asheville, North Carolina 28801
    Colorectal Cancer
    Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Opioid-Induced Constipation
    CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Advanced Solid Tumors
    GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
    Research Site
    Asheville, North Carolina
    Adenocarcinoma of the Pancreas, Advanced Solid Tumors, Cancer, Cancer of Pancreas, Cancer of the Pancreas, Metastases, Metastatic Cancer, Metastatic Pancreatic Cancer, Pancreas Cancer, Pancreatic Cancer, Bone Metastases, Endocrine Cancer, Oncology, Oncology Patients, Solid Tumors, Advanced Malignancy
    A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas
    Research Site
    Asheville, North Carolina
    Gastrointestinal Adenocarcinomas
    Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
    Asheville Gastroenterology Associates
    Asheville, North Carolina 28801
    Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer
    PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Metastatic Renal Cell Carcinoma
    Head to Head Study Epi proColon and FIT
    Asheville Gastroenterology Associates
    Asheville, North Carolina 28801
    Colorectal Cancer